# Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab

> **NCT05139381** · — · UNKNOWN · sponsor: **King's College Hospital NHS Trust** · enrollment: 148 (actual)

## Conditions studied

- Asthma in Children

## Interventions

- **DRUG:** Mepolizumab

## Key facts

- **NCT ID:** NCT05139381
- **Lead sponsor:** King's College Hospital NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-02
- **Primary completion:** 2026-03
- **Final completion:** 2026-03-12
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05139381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05139381, "Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05139381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*